Your browser doesn't support javascript.
loading
Inhibitors of Bcl-2 and Bruton's tyrosine kinase synergize to abrogate diffuse large B-cell lymphoma growth in vitro and in orthotopic xenotransplantation models.
Bertram, Katrin; Leary, Peter John; Boudesco, Christophe; Fullin, Jonas; Stirm, Kristin; Dalal, Vineet; Zenz, Thorsten; Tzankov, Alexandar; Müller, Anne.
Afiliação
  • Bertram K; Institute of Molecular Cancer Research and University of Zurich, Zurich, Switzerland.
  • Leary PJ; Institute of Molecular Cancer Research and University of Zurich, Zurich, Switzerland.
  • Boudesco C; Functional Genomics Center Zurich, University of Zurich, Zurich, Switzerland.
  • Fullin J; Institute of Molecular Cancer Research and University of Zurich, Zurich, Switzerland.
  • Stirm K; Institute of Molecular Cancer Research and University of Zurich, Zurich, Switzerland.
  • Dalal V; Institute of Molecular Cancer Research and University of Zurich, Zurich, Switzerland.
  • Zenz T; German Cancer Research Center, Heidelberg, Germany.
  • Tzankov A; Comprehensive Cancer Center Zurich, Zurich, Switzerland.
  • Müller A; Department of Medical Oncology and Hematology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Leukemia ; 36(4): 1035-1047, 2022 04.
Article em En | MEDLINE | ID: mdl-34795418

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Apoptose Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Apoptose Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça